Showing results (221-230 of 253) with videos related to
Sort By:
Pageof 26
Breast (Edinburgh, Scotland)|February 14, 2026
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysisLuca Arecco, Pedro M Cacilhas, Camila Bobato Lara Gismondi, et al.Breast (Edinburgh, Scotland)|September 25, 2013
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trialHatem A Azim, Francoise Rothé, Claudia Monica Aura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2017
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized TrialAmir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, et al.Breast (Edinburgh, Scotland)|February 10, 2015
Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?Olivia Pagani, Monica Ruggeri, Silvia Manunta, et al.ESMO Open|October 25, 2023
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysisL Arecco, E Blondeaux, M Bruzzone, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2022
ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)S Paluch-Shimon, F Cardoso, A H Partridge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2019
Lucitanib for the Treatment of HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE StudyRina Hui, Alex Pearson, Javier Cortes, et al.European Journal of Cancer (Oxford, England : 1990)|December 12, 2017
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTOS Di Cosimo, C Campbell, H A Azim, et al.JAMA Oncology|September 30, 2016
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical TrialDebora Fumagalli, David Venet, Michail Ignatiadis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 2023
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)S Loibl, H A Azim, T Bachelot, et al.Pageof 26